Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Bioregulators
Khavinson short peptide bioregulator targeting thymic function — Glu-Trp synthetic version.
Peptide B
Bioregulators
Khavinson Lys-Glu dipeptide — immunomodulator with documented life-extension activity in mice.
Typical vial
20 mg
Typical dose
1,000-5,000 mcg
Half-life
Short (minutes); biological effect persists via gene-expression modulation
FDA status
Not FDA approved.
Typical vial
20 mg
Typical dose
1,000-5,000 mcg
Half-life
Short (minutes); biological effect persists via gene-expression modulation
FDA status
Not FDA approved.
Thymagen effects
Vilon effects
Thymagen side effects
Vilon side effects
Thymagen dosing ranges
Immune support
1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year
Vilon dosing ranges
Immune support / anti-aging research
1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year
Thymagen: Khavinson short peptide bioregulator targeting thymic function — Glu-Trp synthetic version. Typical dose 1,000-5,000 mcg. Vilon: Khavinson Lys-Glu dipeptide — immunomodulator with documented life-extension activity in mice. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.
Stacking Thymagen with Vilon is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
Thymagen is typically dosed: Once daily (SubQ) or sublingual for Immune support. Vilon is typically dosed: Once daily (SubQ) or sublingual for Immune support / anti-aging research.
Thymagen: Not FDA approved. Vilon: Not FDA approved.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free